![Matthew Foy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Foy
Direktor/Vorstandsmitglied bei
Pulmocide Ltd.
Profil
Mr. Matthew Foy is an Investor at Asceneuron SA and a Partner at GSK Equity Investments Ltd. He is on the Board of Directors at Akamis Bio Ltd., Fore Biotherapeutics, Inc. and Pulmocide Ltd. Mr. Foy was previously employed as an Independent Director by Decibel Therapeutics, Inc., an Operating Partner by SR One Capital Management LP, a Vice President by Greenhill & Co., Inc., and a Consultant by Longbow Capital Partners LP.
He also served on the board at Progenitor Labs Ltd., Atox Bio Ltd. and Puridify Ltd. He received his undergraduate degree from the University of Oxford, an undergraduate degree from St Peters College Oxford, a graduate degree from the University of Oxford and a graduate degree from St Peters College Oxford.
Aktive Positionen von Matthew Foy
| Unternehmen | Position | Beginn |
|---|---|---|
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01.01.2011 |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Direktor/Vorstandsmitglied | - |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Direktor/Vorstandsmitglied | - |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Direktor/Vorstandsmitglied | - |
Asceneuron SA
 Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Private Equity Investor | 01.09.2015 |
Ehemalige bekannte Positionen von Matthew Foy
| Unternehmen | Position | Ende |
|---|---|---|
Progenitor Labs Ltd.
 Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing | Direktor/Vorstandsmitglied | 25.07.2018 |
Puridify Ltd.
 Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Develops bioprocessing technologies | Direktor/Vorstandsmitglied | 24.11.2017 |
| GREENHILL & CO., INC. | Corporate Officer/Principal | 01.01.2010 |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Matthew Foy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenhill & Co., Inc.
 Greenhill & Co., Inc. Investment Banks/BrokersFinance Operates as an investment bank that provides financial advisory services | Finance |
Longbow Capital Partners LP
 Longbow Capital Partners LP Investment ManagersFinance Longbow is a long/short investment firm focused on investing primarily in the equity securities of companies within the utility, power, energy midstream and related infrastructure sectors. The firm seeks superior risk-adjusted, investment returns with low correlation to the equity market. | Finance |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
St Peters College Oxford
 St Peters College Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Progenitor Labs Ltd.
Progenitor Labs Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to regenerate specific tissues of the human body in response to injury, disease, and ageing | Health Technology |
Asceneuron SA
Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Health Technology |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops inhaled medicines for viral and fungal infections of the respiratory diseases | Health Technology |
Puridify Ltd.
Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Develops bioprocessing technologies | Commercial Services |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One invests in companies located in the United States and the United kingdom. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
